|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Péchoux CL, Sun A, Slotman BJ, De
Ruysscher D, Belderbos J and Gore EM: Prophylactic cranial
irradiation for patients with lung cancer. Lancet Oncol.
17:e277–e293. 2016. View Article : Google Scholar
|
|
3
|
Rosenzweig KE and Gomez JE: Concurrent
chemotherapy and radiation therapy for inoperable locally advanced
non-small-cell lung cancer. J Clin Oncol. 35:6–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun HF, Yang XL, Zhao Y, Tian Q, Chen MT,
Zhao YY and Jin W: Loss of TMEM126A promotes extracellular matrix
remodeling, epithelial-to-mesenchymaltransition, and breast cancer
metastasis by regulating mitochondrial retrograde signaling. Cancer
Lett. 440-441:189–201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oktay MH and Jones JG: TMEM: A novel
breast cancer dissemination marker for the assessment of metastatic
risk. Biomark Med. 9:81–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wrzesiński T, Szelag M, Cieślikowski WA,
Ida A, Giles R, Zodro E, Szumska J, Poźniak J, Kwias Z, Bluyssen HA
and Wesoly J: Expression of pre-selected TMEMs with predicted ER
localization as potential classifiers of ccRCC tumors. BMC Cancer.
15:5182015. View Article : Google Scholar
|
|
8
|
Liu F, Cao QH, Lu DJ, Luo B, Lu XF, Luo RC
and Wang XG: TMEM16A overexpression contributes to tumor invasion
and poor prognosis of human gastric cancer through TGF-β signaling.
Oncotarget. 6:11585–11599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu X, Zhang X, Zhang Y, Jiang G, Mao X and
Jin F: Cytosolic TMEM88 promotes triple-negative breast cancer by
interacting with Dvl. Oncotarget. 6:25034–25045. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Yu X, Jiang G, Miao Y, Wang L,
Zhang Y, Liu Y, Fan C, Lin X, Dong Q, et al: Cytosolic TMEM88
promotes invasion and metastasis in lung cancer cells by binding
DVLS. Cancer Res. 75:4527–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moon EH, Kim MJ, Ko KS, Kim YS, Seo J, Oh
SP and Lee YJ: Generation of mice with a conditional and reporter
allele for Tmem100. Genesis. 48:673–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Somekawa S, Imagawa K, Hayashi H, Sakabe
M, Ioka T, Sato GE, Inada K, Iwamoto T, Mori T, Uemura S, et al:
Tmem100, an ALK1 receptor signaling-dependent gene essential for
arterial endothelium differentiation and vascular morphogenesis.
Proc Natl Acad Sci USA. 109:12064–12069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mizuta K, Sakabe M, Hashimoto A, Ioka T,
Sakai C, Okumura K, Hattammaru M, Fujita M, Araki M, Somekawa S, et
al: Impairment of endothelial-mesenchymal transformation during
atrioventricular cushion formation in TMEM100 null embryos. Dev
Dyn. 244:31–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ou D, Yang H, Hua D, Xiao S and Yang L:
Novel roles of TMEM100: Inhibition metastasis and proliferation of
hepatocellular carcinoma. Oncotarget. 6:17379–17390. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Du Y, Xu S, Jiang Y, Yuan C, Zhou
L, Ma X, Bai Y, Lu J and Ma J: DEPDC1, negatively regulated by
miR-26b, facilitates cell proliferation via the up-regulation of
FOXM1 expression in TNBC. Cancer Lett. 442:242–251. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei TY, Juan CC, Hisa JY, Su LJ, Lee YC,
Chou HY, Chen JM, Wu YC, Chiu SC, Hsu CP, et al: Protein arginine
methyltransferase 5 is a potential oncoprotein that upregulates G1
cyclins/cyclin-dependent kinases and the phosphoinositide
3-kinase/AKT signaling cascade. Cancer Sci. 103:1640–1650. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bild AH, Yao G, Chang JT, Wang Q, Potti A,
Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al:
Oncogenic pathway signatures in human cancers as a guide to
targeted therapies. Nature. 439:353–357. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Robles AI, Arai E, Mathé EA, Okayama H,
Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et
al: An integrated prognostic classifier for Stage I lung
adenocarcinoma based on mRNA, microRNA, and DNA methylation
biomarkers. J Thorac Oncol. 10:1037–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H,
Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, et al:
Increased miR-708 expression in NSCLC and its association with poor
survival in lung adenocarcinoma from never smokers. Clin Cancer
Res. 18:3658–3667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ezponda T, Pajares MJ, Agorreta J,
Echeveste JI, López-Picazo JM, Torre W, Pio R and Montuenga LM: The
oncoprotein SF2/ASF promotes non-small cell lung cancer survival by
enhancing survivinexpression. Clin Cancer Res. 16:4113–4125. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Lu M, Liu B, Huang Y and Wang K:
Inhibition of Ca(2+)-activated Cl(−) channel ANO1/TMEM16A
expression suppresses tumor growth and invasiveness in human
prostate carcinoma. Cancer Lett. 326:41–51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dixit R, Kemp C, Kulich S, Seethala R,
Chiosea S, Ling S, Ha PK and Duvvuri U: TMEM16A/ANO1 is
differentially expressed in HPV-negative versus HPV-positive head
and neck squamous cell carcinoma through promoter methylation. Sci
Rep. 5:166572015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han Z, Wang T, Han S, Chen Y, Chen T, Jia
Q, Li B, Li B, Wang J, Chen G, et al: Low-expression of TMEM100 is
associated with poor prognosis in non-small-cell lung cancer. Am J
Transl Res. 9:2567–2578. 2017.PubMed/NCBI
|
|
27
|
Haag T, Herkt CE, Walesch SK, Richter AM
and Dammann RH: The apoptosis associated tyrosine kinase gene is
frequently hypermethylated in human cancer and is regulated by
epigenetic mechanisms. Genes Cancer. 5:365–374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taubert H, Würl P, Greither T, Kappler M,
Bache M, Bartel F, Kehlen A, Lautenschläger C, Harris LC, Kaushal
D, et al: Stem cell-associated genes are extremely poor prognostic
factors for soft-tissue sarcoma patients. Oncogene. 26:7170–7174.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang M, Wang B, Gao J, Zhang Y, Xu W and
Tao L: Spinosad induces programmed cell death involves
mitochondrial dysfunction and cytochrome C release in Spodoptera
frugiperda Sf9 cells. Chemosphere. 169:155–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu G, Sheng Y, Zhang M and Sun D: A
polysaccharide from the leaves of Aralia elata induces apoptosis in
U-2 OS cells viamitochondrial-dependent pathway. Int J Biol
Macromol. 93:418–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dasgupta P, Kinkade R, Joshi B, Decook C,
Haura E and Chellappan S: Nicotine inhibits apoptosis induced by
chemotherapeutic drugs by up-regulating XIAP and survivin. Proc
Natl Acad Sci USA. 103:6332–6337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Gao Y, Li F, Tong X, Ren Y, Han
X, Yao S, Long F, Yang Z, Fan H, et al: YAP promotes malignant
progression of Lkb1-deficient lung adenocarcinoma through
downstream regulation of survivin. Cancer Res. 75:4450–4457. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Latronico MV, Catalucci D and Condorelli
G: Emerging role of microRNAs in cardiovascular biology. Circ Res.
101:1225–1236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nicolas FE and Lopez-Martinez AF:
MicroRNAs in human diseases. Recent Pat DNA Gene Seq. 4:142–154.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Blitzblau RC and Weidhaas JB: MicroRNA
binding-site polymorphisms as potential biomarkers of cancer risk.
Mol Diagn Ther. 14:335–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH,
Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, et al: ERK activation
globally downregulates miRNAs through phosphorylating Exportin-5.
Cancer Cell. 30:723–736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y and
Zhou T: MicroRNA-106b promotes colorectal cancer cell migration and
invasion by directly targeting DLC1. J Exp Clin Cancer Res.
34:732015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yen CS, Su ZR, Lee YP, Liu IT and Yen CJ:
miR-106b promotes cancer progression in hepatitis B
virus-associated hepatocellular carcinoma. World J Gastroenterol.
22:5183–5192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu F, Gong J, Huang W, Wang Z, Wang M,
Yang J, Wu C, Wu Z and Han B: MicroRNA-106b-5p boosts glioma
tumorigensis by targeting multiple tumor suppressor genes.
Oncogene. 33:4813–4822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carvalheira G, Nozima BH and Cerutti JM:
microRNA-106b-mediated down-regulation of C1orf24 expression
induces apoptosis and suppresses invasion of thyroid cancer.
Oncotarget. 6:28357–28370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X,
Ding Q, Zha X, Sha J and Wang S: Downregulation of miR-106b induced
breast cancer cell invasion and motility in association with
overexpression of matrix metalloproteinase 2. Cancer Sci.
105:18–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
